ライフサイエンスコーパス: procedural

1 platelet strategy was DAPT for 3 months post procedural.

2 s occurring within 30 days, 584 (69.0%) were procedural, 126 (14.9%) ST-related, and 136 (16.1%) spon

3 The primary outcome was procedural (30 days, in-hospital, or perioperative) deat

4 After 30 days, 22 (4.7%) were procedural, 63 (13.5%) were ST-related, and 383 (81.8%)

5 ower technical (84% versus 89%; P<0.001) and procedural (82% versus 87%, P<0.001) success, but simila

6 There was no procedural abrupt closure, slow or no reflow, or perfora

7 s recruitment rate, medication adherence and procedural adherence.

8 Transient procedural adverse effects were seen, but no cell-relate

9 Procedural age was (mean+/-SD) 6+/-3.4 months and weight

10 Procedural and clinical outcomes were compared at 24 mon

11 a safe alternative associated with superior procedural and discharge outcomes.

12 for others, P=0.3), and accounted for 1% of procedural and evaluation and management volumes.

13 The model applies procedural and operational variables to policy constrain

14 Clinical, procedural, and angiographic details were abstracted fro

15 Demographic, procedural, and in-hospital outcome data on patients who

16 s study aimed to examine patient's clinical, procedural, and institutional characteristics that are a

17 Baseline, demographic, procedural, and ophthalmic examination data were recorde

18 Retrospective medical, procedural, and ophthalmologic data were collected, incl

19 Clinical, demographic, procedural, and outcome data were analyzed by dividing p

20 Patient-related, procedural, and short-term outcomes data were characteri

21 codes for surgical site infections and post-procedural antibiotic prescriptions.

22 athogen that was not susceptible to the peri-procedural antibiotic prophylaxis.

23 Procedural anticoagulation with bivalirudin (BIV), trans

24 s in DCB technology but also to disparity in procedural approach, "leave nothing behind" or "combinat

25 Contact tracing in procedural areas was done if a patient with an initial n

26 inal tear, or RD repair was determined using procedural billing codes, and the duration between initi

27 as to determine the relationship between pre-procedural blood pressure and long-term outcome followin

28 ional Group registry undergoing PCI with pre-procedural blood pressure recorded.

29 nipolar signal modification safely decreases procedural burden while ensuring robust 12-month outcome

30 hat there are still important conceptual and procedural challenges in human fear extinction research

31 the extent to which patient characteristics, procedural characteristics (residual mitral valve regurg

32 describe the demographic, angiographic, and procedural characteristics alongside clinical outcomes o

33 examine the association between patient and procedural characteristics and recurrence during follow-

34 gonists: 4), with no differences in baseline-procedural characteristics between groups except for hig

35 hout significant differences in clinical and procedural characteristics between groups.

36 We aimed to describe the clinical/procedural characteristics of a contemporary cohort of p

37 Clinical, anatomic, and procedural characteristics were collected, and Valve Aca

38 ectrocardiographic, computed tomography, and procedural characteristics were collected, including val

39 Procedural characteristics were comparable, except that

40 Clinical and procedural characteristics were recorded and analyzed.

41 ted PVs, lesions created during reablations, procedural characteristics, and acute as well as long-te

42 of the variability explained by patient and procedural characteristics, and annual site volume.

43 ion, periprocedural AKI prophylaxis, and PCI procedural characteristics, Black race was associated wi

44 Between patients' clinical and procedural characteristics, pharmacology and access site

45 ar regression to adjust for patient factors, procedural characteristics, type of admission, and hospi

46 ve, nationwide data on patient selection and procedural characteristics.

47 review a unifying neurocognitive account-the Procedural circuit Deficit Hypothesis (PDH).

48 ulations' results were compared against post-procedural clinical fluoroscopy and echocardiography ima

49 a diagnosis code for NPDR, PDR, or DME or a procedural code for intravitreal injections, pars plana

50 egistry data were extracted if the eye had a procedural code for LTP and a glaucoma diagnosis.

51 Diagnostic and procedural codes related to DED from selected Internatio

52 PCI procedural complexity and patient risk are increasing, a

53 or age, clinical comorbidities, and surgical procedural complexity.

54 The procedural complication rate was 6.6%.

55 EBOA catheter is technically safe with a low procedural complication rate.

56 ble mortality but discrepant length of stay, procedural complication rates and reintervention burdens

57 Peri-procedural complication rates were low (3 stroke [1.4%],

58 oscopy-guided angiography) sclerotherapy and procedural complications (according to Clavien-Dindo cla

59 ation were associated with increased risk of procedural complications and midterm mortality.

60 75.1%; p < 0.001), while procedural time and procedural complications decreased.

61 The number of peri-procedural complications did not differ between the grou

62 cally designed to improve closure and reduce procedural complications has now become the first-line t

63 Procedural complications included 10 bleeding events and

64 Procedural complications occurred in 7 patients (4.7%) i

65 No procedural complications occurred, although one patient

66 The risk of procedural complications requiring open heart surgery wa

67 Procedural complications were more frequent in CA versus

68 No procedural complications were observed in the BS group.

69 Secondary end points included procedural complications within 30 days and blood pressu

70 coronary lesions with high success rate, low procedural complications, and low major adverse cardiova

71 age, genetic syndrome, noncardiac diagnoses, procedural complications, extracorporeal membrane oxygen

72 tent residual stenosis) and safety outcomes (procedural complications, in-hospital major adverse card

73 Secondary outcomes included procedural complications, valve hemodynamics, and qualit

74 on imaging and clinic reports identified any procedural complications.

75 stent thrombosis (ST) or restenosis and peri-procedural complications.

76 We had three cases of peri-procedural complications.

77 outcomes included 30-day major endpoints and procedural complications.

78 dities, anatomical factors, and technical or procedural considerations.

79 Procedural costs were calculated using Medicare reimburs

80 Pre-procedural CT images were post-processed to create 3D pa

81 racted clinical demographic, radiographical, procedural, cytopathological, and surgical data.

82 which 506 (76%) have associated patient and procedural data.

83 there was no difference in the rate of post-procedural death and complications according to access s

84 There were no procedural deaths.

85 The incidence for peri-procedural, delayed-early, and late endocarditis after T

86 Patient demographics, medical history, procedural details, and complications were abstracted.

87 luded demographic, laboratory, clinical, and procedural details.

88 ings suggest that exogenous factors, such as procedural differences between red and white wine produc

89 When procedural difficulty is greater than expected, there ar

90 h samples across descriptive, narrative, and procedural discourse genres were collected from 46 patie

91 onnected speech (storytelling narrative, and procedural discourse).

92 ompared to composite picture description and procedural discourse.

93 ents using a fair process that comports with procedural due process; 6) institutions should employ th

94 patients reduces time to intervention, total procedural duration, blood product transfusion and salva

95 hile reducing the number of applications and procedural duration.

96 load was significantly higher (P < 0.05) and procedural durations were significantly longer (P > 0.00

97 p = 0.04) and had a higher incidence of post-procedural dysphagia or odynophagia (40% vs. 10%; p = 0.

98 cancellous interface and surface anatomy for procedural education.

99 Acute procedural efficacy was demonstrated in 125 patients (98

100 ance can provide significant improvements in procedural efficiency and radiation dose savings for tar

101 xysmal AF significantly increases the global procedural efficiency with similar midterm efficacy.

102 ies raises the prospect of markedly improved procedural efficiency, which could increase patient comf

103 Post-procedural EGD showed a new injury in 86% (n = 43 of 50)

104 rt diseases, congenital heart diseases, peri-procedural electrophysiology applications, and the funct

105 Among those with peri-procedural endocarditis, 47.9% of patients had a pathoge

106 aluate the role of systemic steroids in post-procedural endophthalmitis as the role of intravitreal s

107 s were followed after being treated for post-procedural endophthalmitis that either received systemic

108 ngineering the surgical planning process and procedural environment to optimize workload and performa

109 ng and preparation, and reduce the impact of procedural errors and discrepancies between facilities a

110 s prevalence, clinical impact, pre- and post-procedural evaluation and management, unresolved issues

111 Pre-procedural evaluation included cross-sectional imaging a

112 ctionally consistent numerical reduction for procedural events (4.4% vs. 5.1%; p = 0.078).

113 cedures and identified patient, surgeon, and procedural factors impacting workload.

114 Patient and procedural factors were retrieved retrospectively.

115 fter adjustment for patient, site-level, and procedural factors, FFR-guided revascularization was ass

116 bleeding risks related to both clinical and procedural factors, poses a recurring dilemma in clinica

117 1.17; p = 0.28) after adjusting clinical and procedural factors.

118 rventions and is associated with patient and procedural factors.

119 However, a major reason for procedural failure is arrhythmia originating deep within

120 In 100 vessels with a post procedural FFR <=0.85, and 20 vessels >0.85 high definit

121 In patients with a post procedural FFR <=0.85, intravascular ultrasound revealed

122 coronary intervention FFR <=0.85, mean post procedural FFR was 0.79+/-0.05.

123 s disease 2019, the potential risk of dental procedural generated spray emissions (including aerosols

124 Finally, a procedural guideline for the safety assessment of microb

125 been suggested, no methodological detail nor procedural guideline have been published.

126 eath (Clostridioides difficile infection and procedural haemorrhage); neither was assessed by the inv

127 In 8 studies (n = 675) assessing procedural harms of screening, no serious harms from ini

128 RR(95%CI):0.14(0.08-0.23), P<.001], and post-procedural hypertension [13% vs.18.8%, RR(95% CI):0.69(0

129 ble data from clinical trials, and highlight procedural implications and caveats of new and future in

130 aches to mitigate keloidogenesis are largely procedural in nature.

131 The primary endpoint was a composite of peri-procedural in-hospital or post-discharge bleeding at 1 y

132 We observed a continuous intra-procedural increase of median SBP (+11%) and mean arteri

133 ese arrhythmias or on the optimal timing for procedural interventions in patients with refractory arr

134 Surgery and painful procedural interventions in vulnerable preterm neonates

135 tempted to encourage 8,480 officers to adopt procedural justice policing strategies.

136 ented the system for improving and measuring procedural learning (SIMPL), a workplace-based assessmen

137 channels are required for the development of procedural learning and of pathways that link cortical s

138 s of working memory, executive functions and procedural learning in healthy young adults.

139 he within-seconds time course of early human procedural learning over alternating short periods of pr

140 also slower to initiate swimming in a T-maze procedural learning task but were unimpaired in cognitiv

141 tive functions, and several sub-processes of procedural learning.

142 st, were significant and accounted for early procedural learning.

143 y play an important role in consolidation of procedural learning.

144 However, women had higher rates of procedural life-threatening or major bleeding after TAVR

145 endocarditis was classified into early (peri-procedural [<100 days] and delayed-early [100 days to 1

146 Prasugrel increased spontaneous, but not procedural, major bleeding.

147 Similarly, higher procedural markup was associated with increased hospital

148 Patients with higher pre-procedural mean SBP had a greater chance of a good outco

149 efined as the median of the first five intra-procedural measurements.

150 Yet whether that control encompasses procedural memories, kinematic refinement, or both is st

151 from those based on perception, episodic, or procedural memories.

152 he hippocampal system in the reactivation of procedural memories.

153 abnormalities of brain structures underlying procedural memory (learning and memory that rely on the

154 ensity but failed to enhance sleep-dependent procedural memory consolidation.

155 We describe procedural memory, examine its role in various aspects o

156 [95% CI, 0.67-0.85]) but also with increased procedural MI (RR, 2.48 [95% CI, 1.86-3.31]) with no dif

157 Procedural MI definitions included (1) a category of ele

158 Procedural MI rates were greater in the invasive strateg

159 For procedural MI, the primary MI definition used creatine k

160 rom angina at the expense of higher rates of procedural MI.

161 systematic DES strategy yielded larger post-procedural minimal luminal diameter and a lower incidenc

162 Procedural MIs accounted for 20.1% of all MI events with

163 reatectomy (DP) is a dominant contributor to procedural morbidity, yet risk factors attributable to C

164 There was no CRT procedural mortality and 1 system infection at 54 months

165 access to TAVR, its rate of utilization, and procedural mortality, all of which are important conside

166 and SM leads to excellent outcomes with low procedural mortality, excellent long-term survival, and

167 impaired in tasks of exploratory behavior or procedural motor learning.

168 Varying definitions of procedural myocardial infarction (PMI) are in widespread

169 Numerous definitions for peri-procedural myocardial infarction (PMI) following percuta

170 9 patients (0.45%), which resulted in 1 peri-procedural myocardial infarction and 1 emergent coronary

171 nts treated with PCI had higher rates of non-procedural myocardial infarction and repeat revascularis

172 BG (HR 1.08 [95% CI 0.74-1.59]; p=0.68); non-procedural myocardial infarction was estimated in 8% aft

173 endpoints included all-cause mortality, non-procedural myocardial infarction, and repeat revasculari

174 CE), a composite of all-cause mortality, non-procedural myocardial infarction, repeat revascularisati

175 nfarction; a secondary analysis yielded more procedural myocardial infarctions of uncertain clinical

176 ntion (PCI) practice in England by analyzing procedural numbers, changes in the clinical presentation

177 survey provide a range of clinical and some procedural ophthalmic care.

178 Procedural options included open abdominal, laparoscopic

179 versus 0.9%; P=0.042), while readmission for procedural or medical complications occurred more often

180 e common following CAS while readmission for procedural or medical complications occurred more often

181 feasible for all-cause mortality and certain procedural outcomes but may be less suitable for other e

182 Although procedural outcomes have improved over the years, furthe

183 This study sought to examine DCCV procedural outcomes in patients with CA.

184 patient characteristics, operative data, and procedural outcomes was collected and analysed.

185 center series, no differences in clinical or procedural outcomes were elucidated between patients wit

186 outcome, or only instrument psychometrics or procedural outcomes were reported.

187 widely used in surgery to assess patient and procedural outcomes, but response rates vary widely whic

188 November 2018) to determine device success, procedural outcomes, post-TAVR valve performance, and in

189 ntation techniques have resulted in improved procedural outcomes, whereas indications are progressive

190 aseline characteristics, which may influence procedural outcomes.

191 term risks may guide efforts to improve post-procedural outcomes.

192 Endpoints comprised freedom from AF and procedural parameters.

193 Data from surgical and procedural patients in RE-VERSE AD, a multicenter, open-

194 hemodynamic understanding and also improves procedural planning and allows interventional simulation

195 bstrate mapping has the potential to improve procedural planning and outcomes.

196 d heart team's treatment decision-making and procedural planning in one-fifth of the patients.

197 percutaneous structural interventions, where procedural planning now commonly relies on 3-dimensional

198 helps the interventional radiologist in pre-procedural planning.

199 al relationship between needle size and post-procedural pneumothorax rate.

200 nificant relation with the frequency of post-procedural pneumothorax.

201 eedle-pleural angle on the incidence of post-procedural pneumothorax.

202 Using current-generation devices, procedural, postprocedural, and 1-year outcomes were com

203 Numerous tools and procedural practice guides are available to help facilit

204 ity may be an inappropriate metric to assess procedural quality.

205 lysis showed statistically significant lower procedural rates for catheterization (OR: 0.62, 95% CI:

206 at belief maintenance can be compatible with procedural rationality.

207 We focused on comparative technical or procedural RCTs trials addressing the domains of general

208 or has good anatomical (median score >7) and procedural realism (median score >7).

209 cardiovascular death were categorized as: 1) procedural (related to revascularization); 2) definite o

210 No major device-related or procedural-related safety events occurred up to 3 months

211 Procedural repeatability was less than 5% RSD, and limit

212 relationship between operator experience and procedural results of TMVr.

213 Hospitals depend on procedural revenue to maintain financial health as the r

214 ant to any hospital system that depends upon procedural revenue.

215 eriod, independent of clinical predictors of procedural risk.

216 We analyzed temporal changes in procedural risks among 4597 patients with symptomatic ca

217 has to be taken into consideration, and the procedural risks weighed against the cardiovascular risk

218 ultiple failed ablations, and thus increased procedural risks.

219 e balance between excessive and insufficient procedural safeguards.

220 nd growing operator experience have improved procedural safety and bioprosthetic valve performance.

221 d stenting has underpinned major advances in procedural safety, including opportunity to use smaller

222 Rates of procedural secondary outcomes (eg, aortic valve reinterv

223 Until 2019, guidelines for procedural sedation emphasized a detailed process most a

224 thesia group vs 3.2 (95% CI, 3.0-3.5) in the procedural sedation group (difference, 0.43 [95% CI, 0.0

225 ho received general anesthesia compared with procedural sedation.

226 lacement (TPVR) is associated with a risk of procedural serious adverse events (SAE) and exposure to

227 testing and PPE measures are in wide use in procedural settings.

228 of the study Universal PPE is protective in procedural settings.

229 ndard setting methods used in assessments of procedural skill are currently not evidence-driven or ou

230 Bag-mask ventilation was the only procedural skill identified as highly recommended.

231 These topics and procedural skills were grouped into five broad categorie

232 commended critical care knowledge topics and procedural skills.

233 nce of attitude dissimilarity, resistance to procedural solutions for conflict about that issue, and

234 Pre- and post-procedural SOV diameter was significantly different.

235 Procedural sprays were parametrically studied with varia

236 Multimodal pre-procedural staging identified 47 patients with AM (38%)

237 Variables of interest were nonadherence to procedural standards, use problems with the gown during

238 ed waste, energy requirements, the number of procedural steps, miniaturization, and automation are ju

239 Procedural strategies beyond pulmonary vein isolation ha

240 complication of therapy to be quoted is post-procedural stricture formation, occurring in about 6% of

241 Carotid endarterectomy patients had a lower procedural stroke or death risk compared with carotid ar

242 The procedural stroke or death risk decreased significantly

243 The primary outcome event was any procedural stroke or death, occurring during or within 3

244 Optimal procedural success (<=1+ residual MR without death or ca

245 rization, IVL was safely performed with high procedural success and minimal complications and resulte

246 erse relationship has been described between procedural success and outcomes of all major cardiovascu

247 ion of operator and hospital experience with procedural success and outcomes of patients undergoing C

248 CTO-PCI experiences were directly related to procedural success but were not related to major adverse

249 f studies performing PWI to assess (1) acute procedural success including the ability to achieve PWI

250 Transesophageal echocardiography confirms procedural success on follow-up.

251 otal energy delivery had no association with procedural success or IOP spikes.

252 dies focusing specifically on PWI, the acute procedural success rate for achieving PWI was 94.1% (95%

253 n of a second valve, which led to an overall procedural success rate of 75%.

254 tween prior operator and site experience and procedural success rates (likelihood ratio test=141.12,

255 cess, acute procedural success, and clinical procedural success rates as defined in the clinical prot

256 erate-to-severe calcification portends lower procedural success rates, increased periprocedural major

257 The primary effectiveness endpoint of procedural success was 92.4%; the lower bound of the 95%

258 Procedural success was similar in both (94%).

259 In this study, procedural success was tracked by pacemaker interrogatio

260 Technical and procedural success were higher in MViV.

261 very success, acute technical success, acute procedural success, and clinical procedural success rate

262 Primary endpoints were: 1) procedural success-bilateral, properly positioned CCA fi

263 ted with an increased likelihood of ablation procedural success.

264 The primary effectiveness endpoint was procedural success.

265 ce of SARS-CoV-2 infection identified on pre-procedural surveillance was low in our study, which was

266 nkin scores, successful recanalization, post-procedural symptomatic hemorrhage (sICH), and complicati

267 In all cases clinical and procedural technical successes were obtained (100%).

268 ists and promotes optimal patient selection, procedural-technique, and outcomes.

269 hroughs are described, including advances in procedural techniques to treat arrhythmias and hypertens

270 , 379.22, 379.24, and 379.25), and a Current Procedural Terminology (CPT) code for vitrectomy surgery

271 h edition (ICD-9) procedure codes or Current Procedural Terminology (CPT) codes indicating an eye exa

272 were queried from the database using Current Procedural Terminology (CPT) codes.

273 and 2 years from surgery using Comprehensive Procedural Terminology and International Classification

274 of Diseases, Ninth Revision (ICD-9) Current Procedural Terminology codes and prescriptions for cyclo

275 ated from direct visit billing, CPT (Current Procedural Terminology) billing, and data from the Natio

276 national Classification of Diseases, Current Procedural Terminology, and National Drug Codes director

277 of information to characterize the nature of procedural therapy administered.

278 Procedural thresholds were >5 times the upper reference

279 Total procedural time (minutes) was significantly higher in th

280 m of injury associated with TEE, with longer procedural time and poor or suboptimal image quality det

281 (63.9%, 68.4%, and 75.1%; p < 0.001), while procedural time and procedural complications decreased.

282 oped buried bumper syndrome in the near post-procedural time period and one patient had a small absce

283 reased risk of complex lesions were a longer procedural time under TEE manipulation (for each 10-min

284 oroscopy time, volume of contrast, and total procedural time.

285 out the need for oral anticoagulation if pre-procedural transesophageal echocardiography shows good d

286 e tested, drawing on diverse theoretical and procedural underpinnings.

287 Pre-TAVR and procedural variables associated with post-TAVR eGFR, cha

288 opensity score (25 clinical, anatomical, and procedural variables) and by date of the procedure (with

289 e provides an advantage in the management of procedural, vascular and catheter-related complications.

290 significant differences in overall hospital procedural volume (median hospital procedure volume, 241

291 intervention (PCI), the association between procedural volume and longer-term outcomes is unknown.

292 show an inverse association between operator procedural volume and short-term adverse outcomes after

293 es examined the association between hospital procedural volume as a continuous variable and risk-adju

294 er and more variable at hospitals with a low procedural volume than at hospitals with a high procedur

295 in the United States, requirements regarding procedural volume were mandated by the Centers for Medic

296 cs, including health outcomes, expenditures, procedural volume, and staff employment.

297 These markers include hospital procedural volume, hospital market share, county-level p

298 cedural volume than at hospitals with a high procedural volume.

299 her hospital level characteristics including procedural volume.

300 Outcomes of interest included hospital procedural volume; hospital market share (range, 0-1; re

301 anscatheter Valve Therapy Registry regarding procedural volumes and outcomes from 2015 through 2017.